Samsung Biologics Earns EcoVadis Platinum Sustainability Rating

30 January 2026 | Friday | News


The recognition places Samsung Biologics in the top one percent globally for environmental social and governance performance, reinforcing its position as a trusted sustainable CDMO partner for the global biopharma supply chain.

 Samsung Biologics (KRX: 207940.KS), a leading contract development and manufacturing organization (CDMO), announced that it has received the EcoVadis' Platinum Sustainability Rating, the highest level of recognition for corporate sustainability performance.

 

The Platinum rating places Samsung Biologics in the top one percent of companies evaluated globally by EcoVadis, a leading sustainability assessment platform that measures corporate social responsibility performance across four key areas: Environment, Labor & Human Rights, Ethics, and Sustainable Procurement. The EcoVadis rating is widely referenced by multinational organizations, including global pharmaceutical companies, as a key benchmark for supply chain sustainability and partnership evaluation.

EcoVadis recognized Samsung Biologics for the continued strengthening of its sustainability management systems and execution, reflecting progress across these assessment categories throughout its operations and supply chain. Samsung Biologics previously received the Gold Sustainability Rating in 2024, underscoring a sustained trajectory of improvement.

"This recognition reflects the steady progress we have made in advancing sustainability practices across our operations and supply chain," said John Rim, President and CEO of Samsung Biologics. "As ESG expectations continue to evolve globally, we remain focused on our commitment to responsible business practices that support long-term partnerships and contribute to a more sustainable healthcare ecosystem."

Samsung Biologics has continued to enhance its sustainability initiatives in recent years, including expanding the use of renewable energy across operations and reinforcing ethical and compliance frameworks. The company received an 'A' rating in Water Security from the Carbon Disclosure Project (CDP) in December 2025. As a Champion of the Sustainable Markets Initiative Health Systems Task Force, Samsung Biologics also continues to engage global suppliers in decarbonization efforts and the development of more resilient value chains.

News

Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close